We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urine Test Ensures Asthmatic Children Receive Appropriate Treatment

By LabMedica International staff writers
Posted on 14 Dec 2014
A new urine test could help ensure asthmatic children receive the level of medication they need to manage their illness better and prevent future asthma attacks.

Asthma is a condition that affects the airways and when a person with asthma comes into contact with something that irritates their airways, the muscles around the walls of the airways tighten and become narrower, and the lining of the airways becomes inflamed and starts to swell, causing difficulty in breathing and leading to symptoms of asthma. More...


Scientists at Queen Mary University of London (UK) in partnership with Jagiellonian University Medical School (Krakow, Poland) reviewed 73 children aged 7 to15 years and found that a urine test can accurately measure levels of inflammation within the urine. Testing was carried out among children with asthma on days when they had no symptoms, and the investigators counted the number of days when they received medical attention or missed school due to asthma symptoms. These urine samples were compared with those of children who did not have asthma.

The teams analyzed levels of prostaglandin metabolites which are chemicals released by immune cells that are activated in asthma and found that one of the protective prostaglandins was greatly reduced in those children who went on to have an asthma attack within three months. The UK has among the highest prevalence rates of asthma symptoms in children worldwide, and there were 25,073 emergency hospital admissions for children in the UK in 2011–2012. That means on average there were 69 per day or one every 21 minutes.

Bernard Higgins, MD, Chairman of the British Thoracic Society Executive Committee, and a consultant lung specialist, said, “Doctors manage a large number of children with asthma throughout the UK and this simple test could help them to prescribe tailored treatment. Most of all this is good news for the well-being of our children with asthma, but attacks of asthma are expensive to treat and if this helps us prevent them it could also save vital NHS resources.” The study was presented at The British Thoracic Society Winter Meeting held December 3–5, 2014, in London (UK).

Related Links:

Queen Mary University of London 
Jagiellonian University Medical School 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.